Taha Keilani serves as Executive at AVANT IMMUNOTHERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Taha Keilani has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 2, 2008 involved transacting 500 shares valued at $215.
Taha Keilani currently holds 2,000 shares of AVANT IMMUNOTHERAPEUTICS INC (AVAN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Taha Keilani has been a net neutral trader of AVAN stock. They have purchased $0 and sold $0 worth of shares.
Taha Keilani's most recent insider trade was on Jan 2, 2008, when they sold 500 shares at $0.43 per share.
Get notified when new Form 4 filings are submitted
| 500 |
| $1.37 |
| Discretionary |